Category: Smith & Nephew
Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit
, Boston Scientific
, CareFusion Corp.
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DJO Global
, Ethicon Inc.
, Ironshore Specialty Insurance
, Johnson & Johnson
, Omni Surgical/Spine360
, Smith & Nephew
, Abbott Laboratories
, Genzyme Corp.
The U.S. Health & Human Services Dept. and the Justice Dept. say they collected some $119 million in healthcare fraud penalties from medical device companies during fiscal 2014.
Here's a look at some of the top legal news stories for medical device companies this week: Sales reps level $50m sex discrimination suit against Boston Scientific; Zimmer chooses new bellwethers in NexGen knee implant MDL; Boston Scientific executive's killer gets 17 years; Federal appeals court upholds Smith & Nephew's $85m win over Arthrex; Feds extend Biomet's deferred prosecution deal for another year
A federal appeals court upholds an $85 million patent infringement win for Smith & Nephew over Arthrex.
A pair of high-volume orthopedic surgeons say they're skeptical of so-called 'repless' sales models such as Smith & Nephew's Syncera offering.
A pair of high-volume orthopedists who specialize in hip and knee replacement surgeries are skeptical of generic or "repless" sales models, in which medical device companies offer lower-cost implants without a sales rep on hand to advise during the procedure.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Smith & Nephew buys outs Colombian distributor; Matchmaking for medtech, Greenberg Traurig looks to bring companies together; Zimmer releases post-Biomet merger numbers
The lobbying spend in Washington hit a 16-year high of nearly $33 million in 2014, as the industry continued its fight to repeal Obamacare's medical device tax.
The medical device industry's lobbying spend hit its highest point since 1998 last year, nearing $33 million, as the industry stepped up its campaign to repeal the medical device tax enacted as part of Obamacare.